Conitnuing our series of online Q&A conversations. Join us and hear from leading industry experts, as they cover a wide range of topics relevant for emerging life science companies. Next in the series, BaseLaunch moderates a discussion on Valuation of innovative companies: value of science or...

Basel-based biopharmaceutical Versameb has raised 6.4 million Swiss francs in a Seed C financing round and will put the funds towards expanding its technology platform. Versameb was supported by the healthcare accelerator program BaseLaunch of BaselArea.swiss in 2017/18. With its latest financing round, Versameb has raised 11.8 million...

Versameb raises 6.4 million Swiss francs

Basel-based biopharmaceutical Versameb has raised 6.4 million Swiss francs in a Seed C financing round and will put the funds towards expanding its technology platform. Versameb was supported by the healthcare accelerator program BaseLaunch of BaselArea.swiss in...

Join industry experts and peers in Basel This event co-organized by BaselArea’s BaseLaunch incubator provides an interactive forum and in-depth discussions with drug discovery and development experts.Guest speakers from the biotech and pharmaceutical industry, along with senior managers from Evotec will share insights on how Evotec's...

Basel is among the European biotech hubs with the most exciting companies as named by labiotech.eu. The industry platform highlighted businesses including Actelion, CRISPR Therapeutics and Polyphor. The industry platform labiotech.eu has named the European biotech hubs with the “most exciting biotech companies” based on feedback...